Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Targeting ROS in cancer: rationale and strategies
2024 Standout
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Works of Taisuke Hoshi being referenced
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Taisuke Hoshi | 174 | 88 | 69 | 144 | 12 | 387 | |
| Andrea Lai | 215 | 49 | 61 | 94 | 13 | 366 | |
| Jun Li | 254 | 57 | 40 | 66 | 10 | 372 | |
| Masumi Yoshie | 186 | 105 | 26 | 94 | 14 | 385 | |
| Seok-Hyun Kim | 247 | 87 | 55 | 62 | 17 | 445 | |
| Yasuki Yamamoto | 211 | 70 | 84 | 65 | 12 | 337 | |
| Ralph Klose | 124 | 53 | 39 | 79 | 10 | 355 | |
| Yorihide Okuda | 294 | 68 | 30 | 79 | 16 | 388 | |
| Noélia Che | 272 | 165 | 42 | 81 | 10 | 410 | |
| K Yoshikawa | 179 | 110 | 138 | 67 | 17 | 413 | |
| Goung‐Ran Yu | 278 | 145 | 52 | 39 | 12 | 432 |
All Works
Loading papers...